Price history
¥4,680Latest-10.9%
Drag across the chart to measure the move between two points.Delayed 15 minutes · monthly closing basis
Business overview
A summary lands here once the filings have been read.
Recurring subjects
No threads yetThis company's filings have not been read yet. We are adding them progressively.
Companies sharing a theme
News
Key numbersShowing 8 of 20
PER
39.18How many years of earnings it would take to buy the stock. The market average is generally considered to be around 15.PBR
3.11How many times the company's net assets? Around 1x is generally considered a benchmark.ROE
7.9%Earning power. A figure above 10% is generally considered good.Dividend yield
0.0%The annual dividend as a percentage of the share price.Market capitalization
¥160bnShare price × number of shares. The value of the entire company.Equity ratio
69.4%The proportion of assets funded by money that does not have to be repaid.Operating margin
15.0%The percentage of revenue remaining from the company’s core business.Revenue growth (3 years)
-0.6%The average annual growth in sales over the past three years.What to watch next
Disclosure of progress in expanding production capacity and launching new formulations and products following the substantial increase in capital investment (2025: total capital investment of ¥2,555 million)
Impact MediumLikelihood Medium
Full-year sales and earnings contributions from products linked to ceramide-containing formulation technology and liposome formulation technology, which were identified as research areas in 2024
Impact HighLikelihood Low
Sales performance and continued disclosure of new Foods with Function Claims, such as Suhada Kinenbi Moist Nude Supplement, Suya Sleep Drink, and Ailteine V, including whether these products continue to be listed in subsequent fiscal years
Impact MediumLikelihood Medium
What to watch next
Who owns itTop holders total 64.6%
Listed holders 64.6%Everyone else 35.4%
株式会社エヌ・アイ・アイ36.25%
Okura Shun (大倉 俊)10.83%
The Master Trust Bank of Japan, Ltd. (Trust Account)6.14%
大倉 昊2.93%
Sumitomo Mitsui Banking Corporation2.63%
日本カストディ銀行(信託口)1.87%
The Custody Bank of Japan, Ltd. (Trust Account 4)1.12%
ノエビアホールディングス従業員持株会1.08%
2 other listed holders1.79%
| Holder | Ownership (%) |
|---|---|
| 株式会社エヌ・アイ・アイ | 36.25 |
| Okura Shun (大倉 俊) | 10.83 |
| The Master Trust Bank of Japan, Ltd. (Trust Account) | 6.14 |
| 大倉 昊 | 2.93 |
| Sumitomo Mitsui Banking Corporation | 2.63 |
| 日本カストディ銀行(信託口) | 1.87 |
| The Custody Bank of Japan, Ltd. (Trust Account 4) | 1.12 |
| ノエビアホールディングス従業員持株会 | 1.08 |
| 2 other listed holders | 1.79 |
This company's documents
Filings
Timely disclosures
- 2026-08-03Summary of Financial Results for the Third Quarter of the Fiscal Year Ending September 2026 (Japanese GAAP, Consolidated)
- 2026-05-13Corporate Governance Report 2026/05/13
- 2026-05-13Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending September 2026 [Japanese GAAP] (Consolidated)